Emergent BioSolutions
EBS
#8820
Rank
S$0.29 B
Marketcap
S$5.72
Share price
-7.64%
Change (1 day)
-45.50%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): S$76.37 Million

According to Emergent BioSolutions 's latest financial reports the company's current earnings are S$0.64 Billion. In 2025 the company made an earning of S$0.18 Billion, an increase over its 2024 earnings that were of -S$92.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$76.37 M-58.01%
2025 S$0.18 B-297.64%
2024 -S$92.03 Million-88.82%
2023 -S$0.83 Billion242.73%
2022 -S$0.25 Billion-153.8%
2021 S$0.44 B-20.43%
2020 S$0.56 B278.02%
2019 S$0.14 B27.11%
2018 S$0.11 B-27.12%
2017 S$0.16 B17.21%
2016 S$0.13 B0.45%
2015 S$0.13 B73.51%
2014 S$78.46 M41.36%
2013 S$55.5 M35.2%
2012 S$41.05 M0.4%
2011 S$40.89 M-56.46%
2010 S$93.91 M76.73%
2009 S$53.14 M32.94%
2008 S$39.97 M-5.62%
2007 S$42.35 M
2005 S$61.32 M269.89%
2004 S$16.57 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.55 B 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.83 B 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.81 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-S$14.99 Million-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
S$26.41 M-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.4 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.90 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel